{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:14:01Z","timestamp":1777648441543,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ogc.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T10:15:14Z","timestamp":1396520114000},"page":"241-253","source":"Crossref","is-referenced-by-count":41,"title":["Buprenorphine and Methadone for Opioid Addiction During Pregnancy"],"prefix":"10.1016","volume":"41","author":[{"given":"Ellen L.","family":"Mozurkewich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Rayburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.psc.2012.03.008","article-title":"Treatment of opioid dependence in the setting of pregnancy","volume":"35","author":"Young","year":"2012","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jsat.2011.05.002","article-title":"Changes in methadone maintenance therapy during and after pregnancy","volume":"41","author":"Albright","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2013.10.010","article-title":"Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers","volume":"210","author":"Jones","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2014.02.005_bib4","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy","volume":"119","author":"ACOG Committee on Health Care for Underserved Women","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2014.02.005_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.amjcard.2013.05.037","article-title":"QTc interval screening in an opioid treatment program","volume":"112","author":"Katz","year":"2013","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ogc.2014.02.005_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4212\/cjhp.v65i5.1176","article-title":"Dosing and monitoring of methadone in pregnancy: literature review","volume":"65","author":"Shiu","year":"2012","journal-title":"Can J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehaviour","volume":"22","author":"Jansson","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10826089109053183","article-title":"A\u00a0comparison of the effects of single- and split-dose methadone administration on the fetus: ultrasound evaluation","volume":"26","author":"Wittmann","year":"1991","journal-title":"Int J Addict"},{"issue":"5","key":"10.1016\/j.ogc.2014.02.005_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/j.0001-6349.2005.00510.x","article-title":"Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources","volume":"84","author":"Arlettaz","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5318","key":"10.1016\/j.ogc.2014.02.005_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/233342a0","article-title":"Teratogenicity studies of methadone HCl in rats and rabbits","volume":"233","author":"Markham","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.ogc.2014.02.005_bib12","first-page":"248","article-title":"Comparative teratogenicity of morphine, heroin, and methadone in the hamster","volume":"11","author":"Geber","year":"1969","journal-title":"Pharmacologist"},{"issue":"7","key":"10.1016\/j.ogc.2014.02.005_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0002-9378(75)90492-5","article-title":"Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster","volume":"123","author":"Geber","year":"1975","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib14","first-page":"449","article-title":"Teratogenic activity of methadone hydrochloride in mouse and chick embryos","volume":"30","author":"Jurand","year":"1973","journal-title":"J\u00a0Embryol Exp Morphol"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsgi.2005.11.001","article-title":"Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns","volume":"13","author":"Ramirez-Cacho","year":"2006","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"3 Pt 1","key":"10.1016\/j.ogc.2014.02.005_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajog.2005.02.075","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib17","first-page":"254","article-title":"The effects of methadone treatment on the reactivity of the nonstress test","volume":"74","author":"Archie","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2014.02.005_bib18","first-page":"229","article-title":"Methadone maintenance treatment and the nonstress test","volume":"15","author":"Levine","year":"1995","journal-title":"J\u00a0Perinatol"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000291812","article-title":"Assessment of fetal well-being in methadone-maintained pregnancies: abnormal nonstress tests","volume":"43","author":"Anyaegbunam","year":"1997","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ogc.2014.02.005_bib21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: stillbirth incidence with a case report","volume":"116","author":"Rementeria","year":"1973","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2014.02.005_bib22","first-page":"267.e1","article-title":"The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy","volume":"209","author":"Stewart","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2014.02.005_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jama.1973.03220320013004","article-title":"Methadone maintenance, pregnancy, and progeny","volume":"225","author":"Blinick","year":"1973","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ogc.2014.02.005_bib24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archpedi.1983.02140380026008","article-title":"Neonatal methadone withdrawal. Effect of two treatment regimens","volume":"137","author":"Carin","year":"1983","journal-title":"Am J Dis Child"},{"issue":"6977","key":"10.1016\/j.ogc.2014.02.005_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.310.6977.464","article-title":"Methadone maintenance treatment. Pregnant women taking methadone should be warned about withdrawal symptoms in babies","volume":"310","author":"Kempley","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib26","doi-asserted-by":"crossref","first-page":"70.e1","DOI":"10.1016\/j.ajog.2008.08.041","article-title":"High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome","volume":"200","author":"Lim","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2014.02.005_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1651-2227.2007.00268.x","article-title":"Maternal methadone may cause arrhythmias in neonates","volume":"96","author":"Hussain","year":"2007","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib28","doi-asserted-by":"crossref","first-page":"139.e1","DOI":"10.1016\/j.ajog.2010.10.004","article-title":"Methadone and perinatal outcomes: a retrospective cohort study","volume":"204","author":"Cleary","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2014.02.005_bib29","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1542\/peds.2012-2113","article-title":"Neonatal visual evoked potentials in infants born to mothers prescribed methadone","volume":"131","author":"McGlone","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib30","doi-asserted-by":"crossref","first-page":"F141","DOI":"10.1136\/adc.2009.181701","article-title":"Maternal methadone therapy increases QTc interval in newborn infants","volume":"96","author":"Parikh","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjophthalmol-2013-303967","article-title":"Visual outcome in infants born to drug-misusing mothers prescribed methadone in pregnancy","volume":"98","author":"McGlone","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ogc.2014.02.005_bib32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1360-0443.2012.03844.x","article-title":"Methadone and perinatal outcomes: a prospective cohort study","volume":"107","author":"Cleary","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.ogc.2014.02.005_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2010.11.007","article-title":"Higher maternal doses of methadone does not increase neonatal abstinence syndrome","volume":"40","author":"Pizarro","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0890334403261027","article-title":"Methadone maintenance and lactation: a review of the literature and current management guidelines","volume":"20","author":"Jansson","year":"2004","journal-title":"J\u00a0Hum Lact"},{"issue":"6","key":"10.1016\/j.ogc.2014.02.005_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.0306-5251.2001.01506.x","article-title":"Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing","volume":"52","author":"Begg","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ogc.2014.02.005_bib36","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","author":"American Academy of Pediatrics Committee on Drugs","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2014.02.005_bib37","first-page":"319","year":"1988"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.2007-1182","article-title":"Methadone maintenance and breastfeeding in the neonatal period","volume":"121","author":"Jansson","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005237-200203000-00008","article-title":"Treatment of neonatal abstinence syndrome with breast milk containing methadone","volume":"15","author":"Ballard","year":"2002","journal-title":"J\u00a0Perinat Neonatal Nurs"},{"issue":"6","key":"10.1016\/j.ogc.2014.02.005_bib40","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ogc.2014.02.005_bib41","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2013-1985","article-title":"The transfer of drugs and therapeutics into human breast milk: an update on selected topics","volume":"132","author":"Sachs","year":"2013","journal-title":"Pediatrics"},{"issue":"2006 PAS Annual Meeting","key":"10.1016\/j.ogc.2014.02.005_bib42","first-page":"318","article-title":"Early neurobehavior development of the infant exposed to methadone during pregnancy","volume":"3571","author":"Woodward","year":"2006","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.ogc.2014.02.005_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0b013e318228bb2a","article-title":"Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women","volume":"33","author":"Concheiro","year":"2011","journal-title":"Ther Drug Monit"},{"issue":"1\u20132","key":"10.1016\/j.ogc.2014.02.005_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2011.04.001","article-title":"Management of women treated with buprenorphine during pregnancy","volume":"205","author":"Alto","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2014.02.005_bib46","unstructured":"Center for Substance Abuse Treatment (U.S.). Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication. No (SMA) 04\u20133939 2004."},{"key":"10.1016\/j.ogc.2014.02.005_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1360-0443.2012.04043.x","article-title":"Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication","volume":"107","author":"McNicholas","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ogc.2014.02.005_bib48","series-title":"New Mexico treatment guidelines for medical providers who treat opioid addiction using buprenorphine","author":"Komaromy","year":"2012"},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib49","first-page":"254","article-title":"Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus","year":"2011","journal-title":"J\u00a0Addict Med"},{"issue":"12","key":"10.1016\/j.ogc.2014.02.005_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006318.pub3","article-title":"Maintenance agonist treatments for\u00a0opiate-dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2014.02.005_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"24","key":"10.1016\/j.ogc.2014.02.005_bib52","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after\u00a0methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2014.02.005_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1360-0443.2012.04036.x","article-title":"Maternal Opioid Treatment: Human Experimental Research (MOTHER)\u2014approach, issues and lessons learned","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.ogc.2014.02.005_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.ogc.2014.02.005_bib56","series-title":"Buprenorphine\/naloxone for opioid dependence: clinical practice guideline","author":"Handford","year":"2011"},{"issue":"2","key":"10.1016\/j.ogc.2014.02.005_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3122\/jabfm.2011.02.100155","article-title":"Observational study of buprenorphine\u00a0treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes","volume":"24","author":"O'Connor","year":"2011","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1479-828X.2012.01424.x","article-title":"Buprenorphine exposure in infants of opioid-dependent mothers at birth","volume":"52","author":"Bartu","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2014.02.005_bib59","unstructured":"Reprotox. Buprenorphine. In: An information system on environmental hazards to human reproduction and development. 2013. Available at: http:\/\/reprotox.org\/Members\/AgentDetail.aspx?a=2726. Accessed January 27, 2014."},{"key":"10.1016\/j.ogc.2014.02.005_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before and after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction"},{"issue":"1\u20133","key":"10.1016\/j.ogc.2014.02.005_bib61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"13","key":"10.1016\/j.ogc.2014.02.005_bib62","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3109\/10826084.2010.484474","article-title":"Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale","volume":"45","author":"Jones","year":"2010","journal-title":"Subst Use Misuse"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2014.02.005_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","article-title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure","volume":"107","author":"Coyle","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ogc.2014.02.005_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/bfm.2011.0096","article-title":"Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment","volume":"7","author":"Ilett","year":"2012","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.ogc.2014.02.005_bib65","unstructured":"Toxnet. Buprenorphine. In: Toxicology Data Network, U.S. National Library of Medicine. Available at: http:\/\/toxnet.nlm.nih.gov\/. Accessed January 27, 2014."},{"issue":"4","key":"10.1016\/j.ogc.2014.02.005_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/bfm.2009.9987","article-title":"ABM clinical protocol #21: guidelines for breastfeeding and the drug-dependent woman","volume":"4","author":"Jansson","year":"2009","journal-title":"Breastfeed Med"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854514000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854514000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:21:23Z","timestamp":1746170483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854514000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0889854514000126"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2014.02.005","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}